Consistent with the genome-wide microarray data of human CRC cells (Fig. 5e), PRDM1 counteracted IGFBP3 expression and chemotherapeutic agent-induced apoptosis (Fig. 6d). Here, IGFBP3 is linked to colorectal carcinoma.